Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Tops Revenue Estimates
BRTXBioRestorative Therapies(BRTX) ZACKS·2024-08-14 06:56

Biorestorative Therapies, Inc. (BRTX) came out with a quarterly loss of 0.50pershareversustheZacksConsensusEstimateofalossof0.50 per share versus the Zacks Consensus Estimate of a loss of 0.56. This compares to loss of 0.77pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof10.710.77 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10.71%. A quarter ago, it was expected that this company would post a loss of 0.51 per share when it actually produced a loss of $0.53, delivering a surprise of -3.92%.Over the last four quarters, the compa ...